Ryan McNelley
Managing Director and EMEA Portfolio Valuation Leader
London
Healthcare and Life Sciences: Demonstrating Credible Valuations to Investors
May 23, 2019 | (Conference)
London
The fourth seminar in our portfolio valuation breakfast series hones in on the healthcare and life sciences sector, providing insight and guidance on delivering credible valuations to investors in this space.
Agenda:
|
8:30 a.m. – 9:00 a.m. |
Registration and breakfast |
|
9:00 a.m. – 10:30 a.m. |
Seminar |
(All time slots are in BST)
Topics will include:
- Applying the new IPEV guidelines to the valuation of early stage healthcare and life sciences investments
- Knowing when to recognize value accretion or value impairment
- Corroborating valuations to public market movements
- Top valuation trends in early stage healthcare and life sciences investments
Who Should Attend?
This complimentary event is perfect for fund accounting and valuation roles with any level of exposure to the healthcare and life sciences sector – be it a full portfolio or just one investment in a diversified portfolio.
Connect with us
Portfolio Valuation
Kroll specializes in assisting clients with the valuation of alternative investments, specifically securities and positions for which there are no "active market" quotations.
Valuation Advisory Services
Our valuation experts provide valuation services for financial reporting, tax, investment and risk management purposes.
Kroll is headquartered in New York with offices around the world.
55 East 52nd Street 17 Fl
New York NY 10055
Sign up to receive periodic news, reports, and invitations from Kroll.
Our privacy policy describes how your data will be processed.
© 2024 Kroll, LLC. All rights reserved.
Kroll is not affiliated with Kroll Bond Rating Agency,
Kroll OnTrack Inc. or their affiliated businesses. Read more.